December 20, 2017

AbbVie to Present at the 36th Annual J.P. Morgan Healthcare Conference

Share to Facebook Share to Twitter Share to Linkedin Email Sign Up for Alerts Print

NORTH CHICAGO, Ill., Dec. 20, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018. Richard A. Gonzalez, chairman and chief executive officer, will present at 10:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.    

About AbbVie

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience.  In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.

SOURCE AbbVie

Contact(s)

AbbVie
Media
Adelle Infante
adelle.infante@abbvie.com
(847) 938-8745
AbbVie
Investors
Liz Shea
liz.shea@abbvie.com
(847) 935-2211